Stelara and Infective exacerbation of chronic obstructive airways disease - a phase IV clinical study of FDA data

Summary:

Infective exacerbation of chronic obstructive airways disease is reported as a side effect among people who take Stelara (ustekinumab), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Ventolin, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Infective exacerbation of chronic obstructive airways disease when taking Stelara. It is created by eHealthMe based on reports of 95,658 people who have side effects when taking Stelara from the FDA, and is updated regularly.

What is Stelara?

Stelara has active ingredients of ustekinumab. It is often used in psoriasis. eHealthMe is studying from 96,053 Stelara users. Check the latest studies of Stelara.

What is Infective exacerbation of chronic obstructive airways disease?

Infective exacerbation of chronic obstructive airways disease (severe infective lung disease with chronic obstructive airways disease) is found to be associated with 147 drugs and 332 conditions by eHealthMe. Check the latest studies of Infective exacerbation of chronic obstructive airways disease.

On Jul, 05, 2026

95,658 people reported to have side effects when taking Stelara.
Among them, 19 people (0.02%) have Infective exacerbation of chronic obstructive airways disease.

Could Stelara cause Infective exacerbation of chronic obstructive airways disease?

Among these 19 people:

How long have people been on Stelara when they have Infective exacerbation of chronic obstructive airways disease? *

What is the gender of people who have Infective exacerbation of chronic obstructive airways disease when taking Stelara? *

female: 52.63 %
male: 47.37 %

What is the age of people who have Infective exacerbation of chronic obstructive airways disease when taking Stelara? *

What are other drugs people take besides Stelara? *

What are other side effects people have besides Infective exacerbation of chronic obstructive airways disease? *

H1n1 Influenza (flu (influenza), which is caused by virus influenza a (h1n1)): 3 people, 15.79%
Pneumonia: 2 people, 10.53%
Cardiac Failure Congestive: 2 people, 10.53%
Lower Respiratory Tract Infection: 2 people, 10.53%
Urinary Tract Infection: 1 person, 5.26%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 5.26%
Anaemia Macrocytic (a macrocytic class of anaemia): 1 person, 5.26%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.26%
Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 1 person, 5.26%
Blood Potassium Decreased: 1 person, 5.26%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Stelara and have Infective exacerbation of chronic obstructive airways disease?

- Check whether Infective exacerbation of chronic obstructive airways disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Stelara:

Stelara (96,053 reports)

Infective exacerbation of chronic obstructive airways disease treatments and more:

Infective exacerbation of chronic obstructive airways disease (955 reports)

How severe was Infective exacerbation of chronic obstructive airways disease and when was it recovered:

Infective exacerbation of chronic obstructive airways disease in Stelara

Expand to all the drugs that have ingredients of ustekinumab:

Infective exacerbation of chronic obstructive airways disease and drugs with ingredients of ustekinumab

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Stelara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infective exacerbation of chronic obstructive airways disease:

Infective exacerbation of chronic obstructive airways disease (147 drugs)

Browse all the conditions that are associated with Infective exacerbation of chronic obstructive airways disease:

Infective exacerbation of chronic obstructive airways disease (332 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ustekinumab (the active ingredients of Stelara) and Stelara (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.